Market Insights Health Pharmacies OTC Products

Analgesics (Pharmacies) - Poland

Poland

Revenue in the Analgesics market is projected to reach €0.48bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 9.34%, resulting in a market volume of €0.75bn by 2029.
In global comparison, most revenue will be generated in China (€4,614.00m in 2024).
In relation to total population figures, per person revenues of €11.87 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Analgesics (Pharmacies) market in Poland is experiencing steady growth and development.

Customer preferences: Customers in Poland have a strong preference for over-the-counter analgesics that are easily accessible in pharmacies. They value convenience and affordability when it comes to purchasing pain relief medication. Additionally, there is a growing trend towards natural and herbal remedies, with customers seeking out products that are perceived to be more gentle on the body.

Trends in the market: One significant trend in the Analgesics (Pharmacies) market in Poland is the increasing demand for non-opioid analgesics. This can be attributed to a growing awareness of the potential risks and side effects associated with opioid-based painkillers. Customers are now more inclined to choose safer alternatives that provide effective pain relief without the risk of addiction or other adverse effects. Another trend in the market is the rising popularity of online pharmacies. With the advancement of technology and the convenience it offers, more customers are turning to online platforms to purchase their analgesics. This trend is particularly evident among the younger generation who are comfortable with online shopping and value the convenience of having their medication delivered to their doorstep.

Local special circumstances: Poland has a well-established and regulated pharmaceutical market, with a large number of pharmacies spread across the country. This extensive network of pharmacies ensures easy access to analgesics for customers in both urban and rural areas. Additionally, the Polish government has implemented policies to promote the use of generic medications, which has led to increased affordability and availability of analgesics in the market.

Underlying macroeconomic factors: The growing Analgesics (Pharmacies) market in Poland can be attributed to several underlying macroeconomic factors. Firstly, Poland has experienced steady economic growth in recent years, leading to an increase in disposable income among the population. This has resulted in higher healthcare expenditure, including the purchase of analgesics. Furthermore, the aging population in Poland is driving the demand for analgesics. As people age, they are more likely to experience chronic pain and require regular pain relief medication. This demographic trend is expected to continue in the coming years, further fueling the growth of the Analgesics (Pharmacies) market. In conclusion, the Analgesics (Pharmacies) market in Poland is developing due to customer preferences for accessible and affordable pain relief medication, the increasing demand for non-opioid analgesics, the rise of online pharmacies, the well-established pharmacy network in the country, and the underlying macroeconomic factors of economic growth and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.